Aveanna Healthcare (NASDAQ:AVAH) Price Target Increased to $5.00 by Analysts at Deutsche Bank Aktiengesellschaft

Aveanna Healthcare (NASDAQ:AVAH) had its price objective boosted by Deutsche Bank Aktiengesellschaft from $3.00 to $5.00 in a research note issued to investors on Friday morning, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

Separately, UBS Group lifted their target price on Aveanna Healthcare from $1.70 to $2.80 and gave the company a sell rating in a research report on Friday. Three analysts have rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of Hold and an average target price of $3.45.

Aveanna Healthcare Stock Up 3.9 %

Shares of NASDAQ AVAH traded up $0.17 during midday trading on Friday, hitting $4.71. The stock had a trading volume of 959,390 shares, compared to its average volume of 138,458. The company has a market capitalization of $906.11 million, a PE ratio of -7.85 and a beta of 2.08. The stock has a 50 day simple moving average of $3.15 and a 200-day simple moving average of $2.68. Aveanna Healthcare has a 1 year low of $0.85 and a 1 year high of $5.10.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.01. The company had revenue of $490.65 million for the quarter, compared to analysts’ expectations of $485.05 million. During the same quarter in the previous year, the business posted ($0.06) EPS. As a group, analysts expect that Aveanna Healthcare will post -0.13 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aveanna Healthcare

Institutional investors have recently modified their holdings of the company. SG Americas Securities LLC grew its stake in Aveanna Healthcare by 24.6% during the 4th quarter. SG Americas Securities LLC now owns 23,941 shares of the company’s stock worth $64,000 after purchasing an additional 4,721 shares in the last quarter. Acadian Asset Management LLC grew its stake in Aveanna Healthcare by 185.6% during the 1st quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock worth $72,000 after purchasing an additional 19,096 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Aveanna Healthcare by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock worth $413,000 after purchasing an additional 9,243 shares in the last quarter. Renaissance Technologies LLC grew its stake in Aveanna Healthcare by 155.8% during the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after purchasing an additional 96,600 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in Aveanna Healthcare by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after purchasing an additional 44,970 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.